1.
Outcomes following tacrolimus systemic immunosuppression for penetrating keratoplasty in infants and young children.
Painter Sally L, Rana Mrinal, Barua Ankur, Abbott Joseph, Gupte Girish, Shah Sunil et al.
Eye (Lond)Nov 20214 citationsCohort Study
This study found tacrolimus immunosuppression for pediatric corneal transplants led to higher 1-year graft survival and lower rejection, but severe infections were proportionally higher, offering comparable overall outcomes.